Zydus Cadila starts enrolment for phase 3 trial of covid jab
Zydus Cadila plans to recruit 28,216 volunteers across five sites in four cities, according to information it provided on the government’s clinical trial registry. In contrast, Bharat Biotech enrolled 25,800 participants across 26 sites in 23 cities for its Phase 3 trial of Covaxin